motion sickness in car; micro movement of the eye; lack of focus of the eye; prolonged dizziness; intense headache; Dropping blood pressure; Myalgia; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MOTION SICKNESS (motion sickness in car), EYE MOVEMENT DISORDER (micro movement of the eye), OCULAR DISCOMFORT (lack of focus of the eye), DIZZINESS (prolonged dizziness), HEADACHE (intense headache) and HYPOTENSION (Dropping blood pressure) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced MOTION SICKNESS (motion sickness in car) (seriousness criterion hospitalization), EYE MOVEMENT DISORDER (micro movement of the eye) (seriousness criterion hospitalization), OCULAR DISCOMFORT (lack of focus of the eye) (seriousness criterion hospitalization), DIZZINESS (prolonged dizziness) (seriousness criterion hospitalization), HEADACHE (intense headache) (seriousness criterion hospitalization) and HYPOTENSION (Dropping blood pressure) (seriousness criterion hospitalization). On an unknown date, the patient experienced MYALGIA (Myalgia). At the time of the report, MOTION SICKNESS (motion sickness in car), EYE MOVEMENT DISORDER (micro movement of the eye), OCULAR DISCOMFORT (lack of focus of the eye), DIZZINESS (prolonged dizziness), HEADACHE (intense headache), HYPOTENSION (Dropping blood pressure) and MYALGIA (Myalgia) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: mmHg (Low) Dropping blood pressure. On an unknown date, Cardiac stress test: (Inconclusive) Inconclusive. On an unknown date, Magnetic resonance imaging: (normal) had a cyst but nothing that would cause symptoms.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication includes antibiotic for cyst, 25mg 3xday meclizine for inner ear, and Midodrine HCL 10mg for dropping blood pressure and 10mg Pregnisone for inner ear inflammation. Patient underwent VNG test had no inner ear inflammation and noticed micro movements of the eye No concomitant medication information were reported  Caller wanted to report adverse event.  Callers first dose was on 12apr21, LOT#040B21A, Expiration date 10/2/21.  Caller said his life has been upside down since he got the shot.  First week had intense headache and dizziness.  Second week he had muscle aches and dizziness with limited headaches.  Third week he is having a focusing and dizziness issue.  Caller said he seen doctor and specialist.  Caller had MRI and Stress test.  Caller said MRI came back clean.  Caller said they had a cyst but nothing that would cause symptoms.  Caller said Brain scan came back negative.  Caller said he was completely heathy.  Caller said he also gets motion sickness now since he had the vaccine.  Primary care doctor gave antibiotic for cyst.  PCP thought had something to do with inner ear, 25mg 3xday meclazine,  then the gave Midodrine HCL 10mg for dropping blood pressure.  Caller said he got relief for 3 days then he started getting sick.  Caller went to ER and they took him off the medicine.  Caller when to a ENT doctor.  Caller said took VNG test.  He was prescribed 10mg Pregnisone for inner ear inflammation.  The VNG test proved he didnt have inner ear inflammation.  Caller said his symptoms have been going on for 32 days as of yet.  CAller said he cant go to restaurants because of dizziness and sickness.  Caller said during his VNG test they noticed micro movements of the eye.  His ENT thinks this may be causing the dizziness and lack of focus.  Caller said he will travel to anywhere to get help.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information regarding detailed medical history and diagnostics will help in assessment.